CLINICOPATHOLOGICAL AND MOLECULAR PREDICTIVE FACTORS OF SURVIVAL IN NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH FIRST-LINE IMMUNOTHERAPY WITH OR WITHOUT CHEMOTHERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Di Federico, Alessandro [1 ]
Gelsomino, Francesco [1 ]
De Giglio, Andrea [1 ]
Sperandi, Francesca [1 ]
Melotti, Barbara [1 ]
Ardizzoni, Andrea [1 ]
机构：
[1] IRCCS Azienda Osped Univ Bologna, Bologna, Italy
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
METASTATIC NONSQUAMOUS NSCLC; PEMBROLIZUMAB PLUS CHEMOTHERAPY; SPECIFIED FINAL ANALYSIS; OPEN-LABEL; DOUBLE-BLIND; PHASE-3; PLATINUM; CARBOPLATIN; NIVOLUMAB; PACLITAXEL;
D O I：
10.1136/jitc-2022-SITC2022.0800
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
800
引用
收藏
页码：A833 / A835
页数：3
相关论文
共 50 条
  • [1] CLINICOPATHOLOGICAL AND MOLECULAR PREDICTIVE FACTORS OF SURVIVAL IN NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH FIRST-LINE IMMUNOTHERAPY WITH OR WITHOUT CHEMOTHERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Di Federico, Alessandro
    Gelsomino, Francesco
    De Giglio, Andrea
    Sperandi, Francesca
    Melotti, Barbara
    Ardizzoni, Andrea
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A883 - A883
  • [2] First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysis
    Facchinetti, Francesco
    Di Maio, Massimo
    Perrone, Fabiana
    Tiseo, Marcello
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (06) : 2917 - +
  • [3] Optimal duration of first-line chemotherapy for advanced non-small cell lung cancer: A systematic review with meta-analysis
    da Silveira Nogueira Lima, Joao Paulo
    dos Santos, Lucas Vieira
    Sasse, Emma Chen
    Sasse, Andre Deeke
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (04) : 601 - 607
  • [4] The Efficacy and Safety of First-Line Chemotherapy in Patients With Non-small Cell Lung Cancer and Interstitial Lung Disease: A Systematic Review and Meta-Analysis
    Wang, Yanning
    Miao, Liyun
    Hu, Yuxuan
    Zhou, Yujie
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [5] Atezolizumab as first-line therapy for patients with advanced non-small cell lung cancer: A systematic review and meta-analysis on overall survival
    Marcella, E.
    Susanto, B.
    Chen, S.
    Tandiono, J.
    Tancherla, A.
    Heriyanto, R. S.
    Wijovi, F.
    Kurniawan, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S759 - S759
  • [6] Immunotherapy plus chemotherapy versus chemotherapy alone as first-line treatment for non-small cell lung cancer: A systematic review and meta-analysis.
    Abdelazeem, Basel
    Abbas, Kirellos Said
    Labieb, Fatma
    Arida, Abdul Karim
    El-Shahat, Nahla Ahmed
    Shehata, Joseph
    Kandah, Emad
    Malik, Bilal
    Akanbi, Maxwell Oluwole
    Rafae, Abdul
    Tahir, Nayha
    Wahab, Ahsan
    Ehsan, Hamid
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] The Efficacy of Combining Antiangiogenic Agents with Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer Who Failed First-Line Chemotherapy: A Systematic Review and Meta-Analysis
    Sheng, Jin
    Yang, Yunpeng
    Ma, Yuxiang
    Yang, Bijun
    Zhang, Yaxiong
    Kang, Shiyang
    Zhou, Ting
    Hong, Shaodong
    Qin, Tao
    Hu, Zhihuang
    Fang, Wenfeng
    Huang, Yan
    Zhang, Li
    [J]. PLOS ONE, 2015, 10 (06):
  • [8] Antibiotic treatment and survival in non-small cell lung cancer patients receiving immunotherapy: a systematic review and meta-analysis
    Abdelhamid, Arwa
    Tuminello, Stephanie
    Ivic-Pavlicic, Tara
    Flores, Raja
    Taioli, Emanuela
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (12) : 2427 - 2439
  • [9] First-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer: systematic review and network meta-analysis
    Hess, Lisa M.
    DeLozier, Amy M.
    Natanegara, Fanni
    Wang, Xiaofei
    Soldatenkova, Victoria
    Brnabic, Alan
    Able, Stephen L.
    Brown, Jacqueline
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (12) : 6677 - +
  • [10] The clinical outcome of patients with oligometastatic non-small cell lung cancer treated with first-line immunotherapy
    Miyawaki, Taichi
    Kenmotsu, Hirotsugu
    Doushita, Kousei
    Kodama, Hiroaki
    Nishioka, Naoya
    Miyawaki, Eriko
    Mamesaya, Nobuaki
    Kobayashi, Haruki
    Omori, Shota
    Ko, Ryo
    Wakuda, Kazushige
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S510 - S510
12345